1. Vast testing will be required for quite some time yet, globally. I do not envisage most populations controlling the virus in the short/medium term. It will likely linger & I expect increased testing will become the new norm in society.
2. We have a vaccine for influenza but that still comes round like clock work every winter. All depends if the virus is seasonal & how effective the vaccine is.
Also worth remembering there are 15-20 other applications for the device. The company was founded on HIV testing that is it's core.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-7
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.17M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $4.261K | 143.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 262135 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 192220 | 4 |
View Market Depth
| Last trade - 14.26pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 2.9¢ | 32258 | ||
| Last updated 14.44pm 03/05/2024 ? | |||||
| AT1 (ASX) Chart |